scorecardresearch
Sunday, June 23, 2024
TopicCovid vaccine

Topic: Covid vaccine

Over 2 crore children in 15-18 age group vaccinated with first dose so far, says Mandaviya

According to health ministry, over 91% of the adult population in India has received at least one dose of the vaccine while more than 66% have been vaccinated with both the doses. 

Covaxin doses 86% effective against symptomatic reinfections in health workers: AIIMS study

First-of-its-kind study in India looked at reinfection rates among 4,978 healthcare workers, who had tested positive for Covid between 3 March 2020 and 18 June 2021.

As Covid cases spike, CBSE advises schools to ensure students aged 15-18 get vaccinated fast

Advisory issued by CBSE secretary Anurag Tripathi has been addressed to heads of all CBSE-affiliated schools & regional directors.

Over 41 lakh teens take first Covid shot as India opens up vaccination for young adults

PM Modi had announced on 25 December that adolescents above the age of 15 will be able to take their vaccines from 3 January. The campaign began Monday.

Week after getting emergency nod, Corbevax & Covovax makers await govt guidelines for rollout

According to sources, govt is currently discussing whether these new vaccines can be offered as 'precaution doses', administration of which starts on 10 January.

World has moved on from US, EU’s drug monopoly. India and China are changing IP regulations

Even without an IP waiver from the WTO, China and India are leading the challenge to the West’s vaccine monopoly.

SII has applied for full market authorisation of Covishield, says Adar Poonawalla

'The Modi government now has enough data to consider a full market authorisation,' Serum Institute of India chief executive said in a tweet.

Omicron variant gradually spreading in community, says Delhi Health Minister

Satyendar Jain said that people with no travel history were found infected with the new variant, indicating community spread in the national capital.

Texas hospital’s Covid-19 vaccine Corbevax is ‘not for profit’. It’s a ‘gift to the world’

In a statement, Biological E. said it plans to manufacture 75 million doses a month, anticipating more than 100 million doses per month by February 2022.

Dr Dangs Lab ran screening, safety tests for all 3 phases of Corbevax trial: CEO Arjun Dang

Biological E's Corbevax is the first indigenously developed protein-subunit vaccine against Covid. Overall, it's the third made-in-India coronavirus vaccine after Covaxin and ZyCoV-D.

On Camera

Delhi dating scene has a lawyer-engineer fatigue. Diversify your right swipes

Navigating dating apps is as risky as trading stocks. It makes sense to spread our assets—school teachers, DJs or public policy nerds; diversity is important.

India’s aviation sector set to boom under Modi 3.0 but ‘emerging duopoly’ could hurt consumers

Sector analysts warn that with Go First expected to remain grounded & SpiceJet struggling, industry is likely to consolidate to just 2-3 player market, hampering competition.

Army hospital commandant says no misuse of disability pension grant. ‘Scrutiny at all levels’

Lt Gen Nilakantan says revised Entitlement Rules & Guide to Medical Officers for pensions had been revised to rationalise disability classification, quantification & granting of disability.

Modi’s new universe: the normal irritants of democracy & awkward chai with Rahul Gandhi

Changed reality for Modi govt in its 3rd innings is by no means rise of a new phenomenon. It's a return to old normal where even majorities had to routinely wrestle with storied million mutinies.